ITGAM and chronic hepatitis: FasL expression on CD11b+ Kupffer cells/Mφs was significantly blunted by anti TNF antibody treatment (Fig. 5B), which strongly suggests that these cells and FasL are the final effector of this chronic hepatitis model.